EFFECT OF TUMOR BURDEN AND ROUTE OF ADMINISTRATION ON THE IMMUNOTHERAPEUTIC PROPERTIES OF POLYINOSINIC POLYCYTIDYLIC ACID STABILIZED WITH POLY-L-LYSINE IN CARBOXYMETHYL CELLULOSE [POLY(I,C)-LC]

被引:11
作者
BLACK, PL
HARTMANN, D
PENNINGTON, R
PHILLIPS, H
SCHNEIDER, M
TRIBBLE, HR
TALMADGE, JE
机构
[1] NIPPON LAROCHE,KANAGAWA 247,JAPAN
[2] NIH,FREDERICK CANC RES,PRECLIN SCREENING LAB,FREDERICK,MD 21702
[3] SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406
[4] UNIV NEBRASKA,MED CTR,OMAHA,NE 68198
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1992年 / 14卷 / 08期
关键词
D O I
10.1016/0192-0561(92)90005-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the immunomodulatory and therapeutic activities of poly(I,C) - LC. Mice received a subcutaneous (s.c.) injection of sufficient numbers of MBL-2 lymphoma cells to produce in 1 week either a high or low tumor burden. A week after tumor cell injection, poly(I,C) - LC treatment was initiated; the agent was administered intraperitoneally (i.p.) at 5 mg/kg twice a week or at 2.5 or 0.5 mg/kg every day or as an intravenous (i.v.) injection at 0.5, 0.05, or 0.005 mg/kg three times a week. Poly(I,C) - LC treatment significantly increased antitumor effector cell functions in a variety of organs (including spleen, lungs, and peritoneum), as shown by increased killing of MBL-2 cells in vitro and increased tumor cell killing by natural killer cells and macrophages. Furthermore, prolongation of survival correlated with peritoneal macrophage tumoricidal activity when poly(I,C) - LC was given i.p. and with pulmonary effector cell function (including natural killer, cytolytic T-lymphocyte and macrophage tumoricidal activity) when the agent was administered i.v.
引用
收藏
页码:1341 / 1353
页数:13
相关论文
共 59 条
  • [41] MALATZKY E, 1982, CURRENT CONCEPTS HUM, P371
  • [42] MICHELSON AM, 1985, P SOC EXP BIOL MED, V179, P1
  • [43] NORLUND J, 1970, P SOC EXP BIOL MED, V133, P439
  • [44] EFFECT OF TREATMENT WITH EXOGENOUS INTERFERON, POLYINOSINIC ACID-POLYCYTIDYLIC ACID, OR POLYINOSINIC ACID-POLYCYTIDYLIC ACID-POLY-L-LYSINE COMPLEX ON ENCEPHALOMYOCARDITIS VIRUS-INFECTIONS IN MICE
    OLSEN, GA
    KERN, ER
    GLASGOW, LA
    OVERALL, JC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1976, 10 (04) : 668 - 676
  • [45] REMELS L, 1990, J IMMUNOL, V144, P4477
  • [46] PHASE 1-2 TRIAL OF MULTIPLE-DOSE POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID IN PATIENTS WITH LEUKEMIA OR SOLID TUMORS
    ROBINSON, RA
    DEVITA, VT
    LEVY, HB
    BARON, S
    HUBBARD, SP
    LEVINE, AS
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1976, 57 (03): : 599 - 602
  • [47] SAKURAI M, 1990, ONCOLOGY, V47, P251
  • [48] SARMA PS, 1969, P NATL ACAD SCI USA, V62, P1146
  • [49] INTERFERON - INDUCER OF MACROPHAGE ACTIVATION BY POLYANIONS
    SCHULTZ, RM
    PAPAMATHEAKIS, JD
    CHIRIGOS, MA
    [J]. SCIENCE, 1977, 197 (4304) : 674 - 676
  • [50] Snedecor G.W., 1980, STAT METHODS